151 related articles for article (PubMed ID: 30772460)
1. Combination of microneedles and microemulsions to increase celecoxib topical delivery for potential application in chemoprevention of breast cancer.
Mojeiko G; de Brito M; Salata GC; Lopes LB
Int J Pharm; 2019 Apr; 560():365-376. PubMed ID: 30772460
[TBL] [Abstract][Full Text] [Related]
2. Derma roller® microneedles-mediated transdermal delivery of doxorubicin and celecoxib co-loaded liposomes for enhancing the anticancer effect.
Ahmed KS; Shan X; Mao J; Qiu L; Chen J
Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():1448-1458. PubMed ID: 30889679
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of sonophoresis and a microemulsion on the dermal delivery of celecoxib.
Subongkot T
Drug Deliv; 2020 Dec; 27(1):1087-1093. PubMed ID: 32706279
[TBL] [Abstract][Full Text] [Related]
4. Development and skin penetration pathway evaluation of microemulsions for enhancing the dermal delivery of celecoxib.
Subongkot T; Sirirak T
Colloids Surf B Biointerfaces; 2020 Sep; 193():111103. PubMed ID: 32438237
[TBL] [Abstract][Full Text] [Related]
5. Protein transduction domain-containing microemulsions as cutaneous delivery systems for an anticancer agent.
Pepe D; McCall M; Zheng H; Lopes LB
J Pharm Sci; 2013 May; 102(5):1476-87. PubMed ID: 23436680
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions.
Kelchen MN; Brogden NK
Pharm Res; 2018 Oct; 35(12):228. PubMed ID: 30302631
[TBL] [Abstract][Full Text] [Related]
7. In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib.
Senna TD; Mata Dos Santos HA; Kibwila DM; Leitao AC; Santos Pyrrho AD; de Padula M; Rosas EC; Padua TA; Lara MG; Riemma Pierre MB
Curr Drug Deliv; 2017; 14(7):992-1004. PubMed ID: 28124617
[TBL] [Abstract][Full Text] [Related]
8. Microneedle-Assisted Percutaneous Delivery of a Tetramethylpyrazine-Loaded Microemulsion.
Zu Q; Yu Y; Bi X; Zhang R; Di L
Molecules; 2017 Nov; 22(11):. PubMed ID: 29160824
[TBL] [Abstract][Full Text] [Related]
9. Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel.
Pepe D; Carvalho VF; McCall M; de Lemos DP; Lopes LB
Int J Nanomedicine; 2016; 11():2009-19. PubMed ID: 27274232
[TBL] [Abstract][Full Text] [Related]
10. Potential of Non-aqueous Microemulsions to Improve the Delivery of Lipophilic Drugs to the Skin.
Carvalho VF; de Lemos DP; Vieira CS; Migotto A; Lopes LB
AAPS PharmSciTech; 2017 Jul; 18(5):1739-1749. PubMed ID: 27757922
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy evaluation of different penetration enhancement strategies for dermal delivery of poorly soluble drugs - A case with sertaconazole nitrate.
Bubić Pajić N; Vucen S; Ilić T; O'Mahony C; Dobričić V; Savić S
Eur J Pharm Sci; 2021 Sep; 164():105895. PubMed ID: 34087357
[TBL] [Abstract][Full Text] [Related]
12. Decylglucoside-based microemulsions for cutaneous localization of lycopene and ascorbic acid.
Pepe D; Phelps J; Lewis K; Dujack J; Scarlett K; Jahan S; Bonnier E; Milic-Pasetto T; Hass MA; Lopes LB
Int J Pharm; 2012 Sep; 434(1-2):420-8. PubMed ID: 22692080
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous delivery of α-tocopherol and lipoic acid using microemulsions: influence of composition and charge.
Cichewicz A; Pacleb C; Connors A; Hass MA; Lopes LB
J Pharm Pharmacol; 2013 Jun; 65(6):817-26. PubMed ID: 23647675
[TBL] [Abstract][Full Text] [Related]
14. Topical transdermal chemoprevention of breast cancer: where will nanomedical approaches deliver us?
Mojeiko G; Passos JS; Apolinário AC; Lopes LB
Nanomedicine (Lond); 2021 Aug; 16(19):1713-1731. PubMed ID: 34256574
[TBL] [Abstract][Full Text] [Related]
15. Transdermal delivery of celecoxib and α-linolenic acid from microemulsion-incorporated dissolving microneedles for enhanced osteoarthritis therapy.
Li J; Tian X; Wang K; Jia Y; Ma F
J Drug Target; 2023 Feb; 31(2):206-216. PubMed ID: 36093744
[TBL] [Abstract][Full Text] [Related]
16. Self-Emulsifying Drug Delivery System of Celecoxib for Avoiding Delayed Oral Absorption in Rats with Impaired Gastric Motility.
Yakushiji K; Sato H; Ogino M; Suzuki H; Seto Y; Onoue S
AAPS PharmSciTech; 2020 May; 21(5):135. PubMed ID: 32419073
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous Application of Celecoxib for Inflammatory and Cancer Diseases.
Quiñones OG; Pierre MBR
Curr Cancer Drug Targets; 2019; 19(1):5-16. PubMed ID: 29714143
[TBL] [Abstract][Full Text] [Related]
18. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
[TBL] [Abstract][Full Text] [Related]
19. Enhancement in the Transdermal and Localized Delivery of Honokiol Through Breast Tissue.
Gao X; Patel MG; Bakshi P; Sharma D; Banga AK
AAPS PharmSciTech; 2018 Nov; 19(8):3501-3511. PubMed ID: 30259402
[TBL] [Abstract][Full Text] [Related]
20. Formulation Optimization and Ex Vivo and In Vivo Evaluation of Celecoxib Microemulsion-Based Gel for Transdermal Delivery.
Cao M; Ren L; Chen G
AAPS PharmSciTech; 2017 Aug; 18(6):1960-1971. PubMed ID: 27914040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
